Task Force Advocates Making Device Registries Better Than Sum Of Their Parts
This article was originally published in SRA
Medical device registries need much better coordination so they reflect the same set of device identifiers, shared minimum data elements and definitions and the ability to pool complementary data, according to a US Food and Drug Administration-endorsed task force report1.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.